Medication info
Losartan 50 mg (Losartan Potassium)

Losartan 50 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Yuhan Corporation
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200500565 · Notified 2005.10.28 · Insurance code 642100300

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes and hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time every day. Hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in two divided doses daily, or, if necessary, increased to 100 mg once daily. Hypertension: If blood pressure is not controlled with this medicine alone, it may be coadministered with other antihypertensive agents (e.g., a low-dose diuretic). An additive effect has been observed with coadministration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be coadministered with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). No initial dose adjustment is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years and older, weighing 20 kg or more and less than 50 kg, who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years and older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Ingredients

Manufacturer
Yuhan Corporation

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes and hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used to effectively lower blood pressure in patients with hypertension. Additionally, it helps in the treatment of kidney disease in patients with type 2 diabetes, particularly those with high blood pressure. This contributes to blood pressure control and the protection of kidney function.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time every day. Hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in two divided doses daily, or, if necessary, increased to 100 mg once daily. Hypertension: If blood pressure is not controlled with this medicine alone, it may be coadministered with other antihypertensive agents (e.g., a low-dose diuretic). An additive effect has been observed with coadministration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be coadministered with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). No initial dose adjustment is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years and older, weighing 20 kg or more and less than 50 kg, who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years and older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Precautions

This drug can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters. Therefore, women who are pregnant or might become pregnant should not take this medication. Patients who have an allergic reaction to this drug or have severely impaired liver function, as well as those with certain genetic disorders should not use this medication. Elderly patients, patients with weak kidney function, and patients at risk of significantly low blood pressure should exercise extra caution when using this drug and should take it cautiously as directed by their physician. While using this medication, it is necessary to regularly check blood pressure, kidney function, serum potassium levels, etc., for any abnormalities, as hyperkalemia may occur. It is advisable not to take potassium supplements or medications containing potassium simultaneously. This drug lowers blood pressure, so if symptoms of hypotension (dizziness, fainting, etc.) occur, consult a doctor immediately, and in serious cases, discontinuation may be necessary. Occasionally, allergic reactions such as skin rashes, hives, and angioedema may occur, so it is crucial to inform medical personnel immediately if such symptoms develop. Use caution while driving or operating machinery during treatment, especially at the onset of therapy or when changing the dose. Moreover, taking this medication with grapefruit juice may decrease its effectiveness, so it is best to avoid grapefruit juice. Women who are pregnant or breastfeeding should not take this medication and should consult a physician for alternative treatment options if necessary. This drug is not to be used in children, particularly those under 6 years old or in children with significantly impaired kidney function. In case of overdose, symptoms such as hypotension and heart rate abnormalities may occur, requiring immediate medical treatment, and this drug is not eliminated by dialysis, so emergency treatment is necessary.

Side effects

  • Decreased skull formation
  • anuria
  • hypotension
  • renal failure
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorders
  • pharyngitis
Show 123 more
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • swelling
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • skin peeling on palms
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • myotonia
  • arthralgia
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory impairment
  • decreased libido
  • memory impairment
  • migraine
  • hyperesthesia
  • sensory disturbances
  • peripheral neuropathy
  • panic disorder
  • sleep disorders
  • hypersomnia
  • tremors
  • dizziness
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • pulmonary congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity reactions
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning and pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • visual impairment
  • erectile dysfunction
  • nocturia
  • frequency
  • urethral infection
  • dry cough
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • liver dysfunction
  • hepatitis
  • intestinal vascular edema
  • malaise
  • thrombocytopenia
  • elevated creatine kinase
  • rhabdomyolysis
  • acute renal failure
  • erythroderma
  • hyponatremia
  • elevated ALT
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beat
  • atrial fibrillation
  • hypoglycemia
  • weakness
  • hunger
  • cold sweat
  • tremors
  • decreased concentration
  • convulsions
  • altered consciousness

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent air and moisture from entering. It is best to keep it at room temperature between 1°C and 30°C. Storing it this way helps maintain the drug's efficacy over time.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.